Insect cells for antibody production: Evaluation of an efficient alternative

Journal of Biotechnology

Volumn 153, Issue 3-4, 2011, Pages 160-166

  Palmberger, Dieter ^a   Rendić, Dubravko ^a   Tauber, Philipp ^a   Krammer, Florian ^a   Wilson, Iain B H ^a   Grabherr, Reingard ^a  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

" High Five" cells; Baculovirus; Insect cells; Monoclonal antibodies; N linked glycosylation

Indexed keywords

'' HIGH FIVE'' CELLS; ANTIBODY PRODUCTION; ANTIGEN BINDING; BACULOVIRUS; CHINESE HAMSTER OVARY CELLS; GLYCOFORMS; HEAVY CHAIN; INSECT CELL LINES; INSECT CELL SYSTEMS; INSECT CELLS; MAMMALIAN CELLS; N-GLYCANS; N-LINKED; N-LINKED GLYCOSYLATION; OLIGOSACCHARIDE STRUCTURE; PRODUCT YIELDS; SPODOPTERA FRUGIPERDA; THERAPEUTIC MONOCLONAL ANTIBODIES; TRANSIENT EXPRESSION; TRICHOPLUSIA NI;

AMINO ACIDS; ANTIGENS; CELL CULTURE; ESTERIFICATION; GLYCOSYLATION; MAMMALS; MONOCLONAL ANTIBODIES; SURFACE PLASMON RESONANCE;

CELLS;

ASPARAGINE; FUCOSE; GLYCOPROTEIN GP 41; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN HEAVY CHAIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 3D6; OLIGOSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; GLYCOSYLATION; HEAVY CHAIN; HUMAN; HUMAN CELL; INSECT CELL; INSECT CELL CULTURE; LEPIDOPTERA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIBODIES, MONOCLONAL; BACULOVIRIDAE; CELL LINE; CHO CELLS; CRICETINAE; CRICETULUS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FUCOSE; GLYCOSYLATION; HUMANS; PROTEIN BINDING; PROTEIN ENGINEERING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPODOPTERA;

CRICETULUS GRISEUS; HEXAPODA; MAMMALIA; SPODOPTERA FRUGIPERDA; TRICHOPLUSIA NI;

EID: 79955775743     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2011.02.009     Document Type: Article

References (35)

1. Altmann F. The role of protein glycosylation in allergy. Int. Arch. Allergy Immunol. 2007, 142:99-115.
2. Betenbaugh M.J., Tomiya N., Narang S., Hsu J.T., Lee Y.C. Biosynthesis of human-type N-glycans in heterologous systems. Curr. Opin. Struct. Biol. 2004, 14:601-606.
3. Beuger V., Kunkele K.P., Koll H., Gartner A., Bahner M., Burtscher H., Klein C. Short-hairpin-RNA-mediated silencing of fucosyltransferase 8 in Chinese-hamster ovary cells for the production of antibodies with enhanced antibody immune effector function. Biotechnol. Appl. Biochem. 2009, 53:31-37.
4. Birch J.R., Racher A.J. Antibody production. Adv. Drug Deliv. Rev. 2006, 58:671-685.
5. Boss M., Kenten J., Wood C., Emtage J. Assembly of functional antibodies from immunoglobulin heavy and light chains synthesised in E. coli. Nucleic Acids Res. 1984, 12:3791-3806.
6. Breitbach K., Jarvis D.L. Improved glycosylation of a foreign protein by Tn-5B1-4 cells engineered to express mammalian glycosyltransferases. Biotechnol. Bioeng. 2001, 74:230-239.
7. Choi B., Bobrowicz P., Davidson R., Hamilton S., Kung D., Li H., Miele R., Nett J., Wildt S., Gerngross T. Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast Pichia pastoris. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:5022-5027.
8. Chung C.H., Mirakhur B., Chan E., Le Q.T., Berlin J., Morse M., Murphy B.A., Satinover S.M., Hosen J., Mauro D., Slebos R.J., Zhou Q., Gold D., Hatley T., Hicklin D.J., Platts-Mills T.A. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N. Engl. J. Med. 2008, 358:1109-1117.
9. Dai X., Jayapal M., Tay H., Reghunathan R., Lin G., Too C., Lim Y., Chan S., Kemeny D., Floto R., Smith K., Melendez A., MacAry P. Differential signal transduction, membrane trafficking, and immune effector functions mediated by FcgammaRI versus FcgammaRIIa. Blood 2009, 114:318-327.
10. Gasser B., Mattanovich D. Antibody production with yeasts and filamentous fungi: on the road to large scale?. Biotechnol. Lett. 2007, 29:201-212.
11. Hollister J., Grabenhorst E., Nimtz M., Conradt H., Jarvis D.L. Engineering the protein N-glycosylation pathway in insect cells for production of biantennary, complex N-glycans. Biochemistry 2002, 41:15093-15104.
12. Huang L., Biolsi S., Bales K.R., Kuchibhotla U. Impact of variable domain glycosylation on antibody clearance: an LC/MS characterization. Anal. Biochem. 2006, 349:197-207.
13. Huang Y.M., Hu W., Rustandi E., Chang K., Yusuf-Makagiansar H., Ryll T. Maximizing productivity of CHO cell-based fed-batch culture using chemically defined media conditions and typical manufacturing equipment. Biotechnol. Prog. 2010, 26:1400-1410.
14. Jarvis D.L. Baculovirus-insect cell expression systems. Methods Enzymol. 2009, 463:191-222.
15. Jarvis D.L., Kawar Z.S., Hollister J.R. Engineering N-glycosylation pathways in the baculovirus-insect cell system. Curr. Opin. Biotechnol. 1998, 9:528-533.
16. Jefferis R. Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action. Trends Pharmacol. Sci. 2009, 30:356-362.
17. Jefferis R., Lund J. Interaction sites on human IgG-Fc for FcgammaR: current models. Immunol. Lett. 2002, 82:57-65.
18. Kanda Y., Yamada T., Mori K., Okazaki A., Inoue M., Kitajima-Miyama K., Kuni-Kamochi R., Nakano R., Yano K., Kakita S., Shitara K., Satoh M. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types. Glycobiology 2007, 17:104-118.
19. Kelley B. Industrialization of mAb production technology: the bioprocessing industry at a crossroads. MAbs 2009, 1:443-452.
20. Kipriyanov S., Little M. Generation of recombinant antibodies. Mol. Biotechnol. 1999, 12:173-201.
21. Koprivova A., Stemmer C., Altmann F., Hoffmann A., Kopriva S., Gorr G., Reski R., Decker E.L. Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans. Plant Biotechnol. J. 2004, 2:517-523.
22. Kost T.A., Condreay J.P., Jarvis D.L. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat. Biotechnol. 2005, 23:567-575.
23. Li H., Sethuraman N., Stadheim T.A., Zha D., Prinz B., Ballew N., Bobrowicz P., Choi B.K., Cook W.J., Cukan M., Houston-Cummings N.R., Davidson R., Gong B., Hamilton S.R., Hoopes J.P., Jiang Y., Kim N., Mansfield R., Nett J.H., Rios S., Strawbridge R., Wildt S., Gerngross T.U. Optimization of humanized IgGs in glycoengineered Pichia pastoris. Nat. Biotechnol. 2006, 24:210-215.
24. Luckow V.A. Baculovirus systems for the expression of human gene products. Curr. Opin. Biotechnol. 1993, 4:564-572.
25. Muller N., Derouazi M., Van Tilborgh F., Wulhfard S., Hacker D.L., Jordan M., Wurm F.M. Scalable transient gene expression in Chinese hamster ovary cells in instrumented and non-instrumented cultivation systems. Biotechnol. Lett. 2007, 29:703-711.
26. Nechansky A., Schuster M., Jost W., Siegl P., Wiederkum S., Gorr G., Kircheis R. Compensation of endogenous IgG mediated inhibition of antibody-dependent cellular cytotoxicity by glyco-engineering of therapeutic antibodies. Mol. Immunol. 2007, 44:1815-1817.
27. Rendic D., Wilson I.B., Paschinger K. The glycosylation capacity of insect cells. Croatia Chimica Acta 2008, 81:7-21.
28. Rendić D., Wilson I.B., Lubec G., Gutternigg M., Altmann F., Léonard R. Adaptation of the " in-gel release method" to N-glycome analysis of low-milligram amounts of material. Electrophoresis 2007, 28:4484-4492.
29. Sambrook J., Russel D.W. Molecular Cloning 2001, Cold Spring Harbor Laboratory Press, New York, USA. Third edition.
30. Satoh M., Iida S., Shitara K. Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies. Expert Opin. Biol. Ther. 2006, 6:1161-1173.
31. Shinkawa T., Nakamura K., Yamane N., Shoji-Hosaka E., Kanda Y., Sakurada M., Uchida K., Anazawa H., Satoh M., Yamasaki M., Hanai N., Shitara K. The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J. Biol. Chem. 2003, 278:3466-3473.
32. Sibéril S., Dutertre C., Boix C., Bonnin E., Ménez R., Stura E., Jorieux S., Fridman W., Teillaud J. Molecular aspects of human FcgammaR interactions with IgG: functional and therapeutic consequences. Immunol. Lett. 2006, 106:111-118.
33. Stoger E., Sack M., Fischer R., Christou P. Plantibodies: applications, advantages and bottlenecks. Curr. Opin. Biotechnol. 2002, 13:161-166.
34. Summers M.D., Smith G.E. A manual of methods for baculovirus vectors and insect cell culture procedures. Texas Agric. Exp. Station Bull. 1987, 1555.
35. Wickham T.J., Nemerow G.R. Optimization of growth methods and recombinant protein production in BTI-Tn-5B1-4 insect cells using the baculovirus expression system. Biotechnol. Prog. 1993, 9:25-30.